Welcome to our dedicated page for PLCI news (Ticker: PLCI), a resource for investors and traders seeking the latest updates and insights on PLCI stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PLCI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PLCI's position in the market.
Pelican Acquisition II Corporation (NASDAQ: PLCIU) priced its initial public offering of 7,500,000 units at $10.00 per unit on July 23, 2026, for total gross proceeds of $75 million. The units are expected to begin trading on the Nasdaq Capital Market under the ticker “PLCIU” on July 24, 2026.
Each unit includes one ordinary share and one right, with each right entitling the holder to receive one‑tenth of one ordinary share upon completion of an initial business combination. Once separated, the ordinary shares and rights are expected to trade under “PLCI” and “PLCIR”, respectively. The offering is expected to close on July 27, 2026, subject to customary conditions. EarlyBirdCapital is sole book‑running manager and holds a 45‑day option to purchase up to 1,125,000 additional units at the IPO price to cover over‑allotments.